NASDAQ:NMTC NeuroOne Medical Technologies (NMTC) Stock Price, News & Analysis $1.33 0.00 (0.00%) Closing price 09/25/2026 04:00 PM EasternExtended Trading$1.33 0.00 (0.00%) As of 09/25/2026 05:14 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsInsider TradesNews and TrendsOptions ChainOwnershipSEC Filings About NeuroOne Medical Technologies Stock (NASDAQ:NMTC) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get NMTC alerts:Sign Up Key Stats Today's Range$1.28▼$1.3550-Day Range$1.30▼$2.1852-Week Range$1.28▼$6.96Volume120,791 shsAverage Volume134,400 shsMarket Capitalization$12.12 millionP/E RatioN/ADividend YieldN/APrice Target$7.33Consensus RatingHold Company Overview NeuroOne Medical Technologies Corp. is a medical technology company focused on developing, manufacturing and commercializing thin-film electrode technology for neurological applications. Its products are designed to support the recording, monitoring and stimulation of electrical activity in the brain and nervous system, with potential uses in the diagnosis and treatment of neurological disorders. The company’s product portfolio includes the Evo family of electrode products, including devices used for stereoelectroencephalography and cortical monitoring. NeuroOne has also developed the OneRF Ablation System, a platform intended to deliver radiofrequency energy for targeted tissue ablation. The company continues to pursue additional applications for its technology in areas such as epilepsy, neuromodulation and other central and peripheral nervous system procedures. NeuroOne is based in Eden Prairie, Minnesota, and serves the medical device market primarily through regulatory development, product commercialization and relationships with healthcare providers and industry partners. The company was established to advance thin-film electrode designs intended to offer a less invasive alternative to certain conventional neurological electrodes.AI Generated. May Contain Errors. Read More NeuroOne Medical Technologies Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks79th Percentile Overall ScoreNMTC MarketRank™: NeuroOne Medical Technologies scored higher than 79% of companies evaluated by MarketBeat, and ranked 112th out of 903 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion3.6 / 5Analyst RatingHold Consensus RatingNeuroOne Medical Technologies has received a consensus rating of Hold. The company's average rating score is 2.40, and is based on no strong buy ratings, 3 buy ratings, 1 hold rating, and 1 sell rating.Upside PotentialNeuroOne Medical Technologies has a consensus price target of $7.33, representing about 451.4% upside from its current price of $1.33.Amount of Analyst CoverageNeuroOne Medical Technologies has only been the subject of 2 research reports in the past 90 days.Read more about NeuroOne Medical Technologies' stock forecast and price target. Earnings and Valuation0.0 / 5Proj. Earnings GrowthDecreasing Earnings GrowthEarnings for NeuroOne Medical Technologies are expected to decrease in the coming year, from ($0.39) to ($0.71) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of NeuroOne Medical Technologies is -1.40, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of NeuroOne Medical Technologies is -1.40, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioNeuroOne Medical Technologies has a P/B Ratio of 1.56. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.Read more about NeuroOne Medical Technologies' valuation and earnings. Short Interest5.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted0.94% of the float of NeuroOne Medical Technologies has been sold short.Short Interest Ratio / Days to CoverNeuroOne Medical Technologies has a short interest ratio ("days to cover") of 0.66, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in NeuroOne Medical Technologies has recently decreased by 68.74%, indicating that investor sentiment is improving significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldNeuroOne Medical Technologies does not currently pay a dividend.Dividend GrowthNeuroOne Medical Technologies does not have a long track record of dividend growth. News and Social Media3.6 / 5News Sentiment0.71 News SentimentNeuroOne Medical Technologies has a news sentiment score of 0.71. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Healthcare companies.News Coverage This WeekMarketBeat has tracked 4 news articles for NeuroOne Medical Technologies this week, compared to 2 articles on an average week.Search Interest6 people have searched for NMTC on MarketBeat in the last 30 days. This is an increase of 200% compared to the previous 30 days.MarketBeat Follows2 people have added NeuroOne Medical Technologies to their MarketBeat watchlist in the last 30 days. Company Ownership3.5 / 5Insider TradingAcquiring Shares Net Insider BuyingOver the last three months, insiders have purchased a net $35,199.00 in company stock, which represents 0.2905% of the company's market cap.Insider Buying vs. Insider SellingIn the past three months, NeuroOne Medical Technologies insiders have bought 110.69% more of their company's stock than they have sold. Specifically, they have bought $66,999.00 in company stock and sold $31,800.00 in company stock.Percentage Held by Insiders11.80% of the stock of NeuroOne Medical Technologies is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by Institutions16.07% of the stock of NeuroOne Medical Technologies is held by institutions.Read more about NeuroOne Medical Technologies' insider trading history. Receive NMTC Stock News and Ratings via Email Sign-up to receive the latest news and ratings for NeuroOne Medical Technologies and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. NMTC Stock News HeadlinesAnalyzing Fresenius SE & Co. (OTCMKTS:FSNUY) & NeuroOne Medical Technologies (NASDAQ:NMTC)September 26 at 4:59 AM | americanbankingnews.comNeuroOne Medical Technologies Corporation (NASDAQ:NMTC) Receives $7.33 Average Price Target from BrokeragesSeptember 23, 2026 | americanbankingnews.comDo NOT Buy SpaceX – Do This InsteadSpaceX just went public - and Whitney Tilson, Harvard MBA and 30-year Wall Street veteran, says buying in could be a costly mistake. He calls it among the most overhyped, overvalued large-cap offerings ever pushed onto everyday investors. Tilson believes a rare economic event is approaching - one with serious consequences for your portfolio this summer. He has prepared a free analysis outlining what he sees and the specific steps he recommends taking now.September 27 at 1:00 AM | Stansberry Research (Ad)NeuroOne® Expands U.S. Commercialization of FDA-Cleared OneRF® Trigeminal Nerve Ablation System with New Southern California Distribution AgreementSeptember 17, 2026 | globenewswire.comDavid Wambeke Purchases 33,333 Shares of NeuroOne Medical Technologies (NASDAQ:NMTC) StockSeptember 9, 2026 | insidertrades.comNeuroOne Announces Successful Robotic-Assisted Drug Delivery Using Next-Generation StereoCED(TM) PlatformAugust 27, 2026 | finance.yahoo.comNeuroOne (NMTC) Q3 2026 Earnings Call TranscriptAugust 20, 2026 | finance.yahoo.comNeuroOne Medical Technologies Corporation (NMTC) Q3 2026 Earnings Call TranscriptAugust 13, 2026 | seekingalpha.comSee More Headlines NMTC Stock Analysis - Frequently Asked Questions How have NMTC shares performed this year? NeuroOne Medical Technologies' stock was trading at $4.5480 at the start of the year. Since then, NMTC shares have decreased by 70.8% and is now trading at $1.33. How were NeuroOne Medical Technologies' earnings last quarter? NeuroOne Medical Technologies Corporation (NASDAQ:NMTC) posted its earnings results on Thursday, August, 13th. The company reported ($0.28) EPS for the quarter, missing the consensus estimate of ($0.21) by $0.07. The company earned $1.97 million during the quarter, compared to the consensus estimate of $2.17 million. NeuroOne Medical Technologies had a negative trailing twelve-month return on equity of 128.12% and a negative net margin of 71.50%. Read the conference call transcript. When did NeuroOne Medical Technologies' stock split? NeuroOne Medical Technologies shares reverse split on the morning of Wednesday, April 15th 2026.A 1-6 reverse split was announced. The number of shares owned by shareholders was adjusted after the market closes on Tuesday, April 14th 2026. An investor that had 100 shares of stock prior to the reverse split would have 17 shares after the split. When did NeuroOne Medical Technologies IPO? NeuroOne Medical Technologies (NMTC) raised $500,000 in an initial public offering on Wednesday, May 26th 2021. The company issued 10,000,000 shares at $0.05 per share. Who are NeuroOne Medical Technologies' major shareholders? Top institutional shareholders of NeuroOne Medical Technologies include Bard Associates Inc. (3.51%), BlackRock Inc. (0.29%), Citadel Advisors LLC (0.17%) and Susquehanna International Group LLP (0.15%). Insiders that own company stock include David J Wambeke, Ronald W Mcclurg, Mark Christianson and Christopher Volker. View institutional ownership trends. How do I buy shares of NeuroOne Medical Technologies? Shares of NMTC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of NeuroOne Medical Technologies own? Based on aggregate information from My MarketBeat watchlists, some other companies that NeuroOne Medical Technologies investors own include Schwab US Large-Cap ETF (SCHX), NVIDIA (NVDA), Advanced Micro Devices (AMD), NIO (NIO), Ford Motor (F), Meta Platforms (META) and Plug Power (PLUG). Company Calendar Last Earnings8/13/2026Today9/27/2026Fiscal Year End9/30/2026Next Earnings (Estimated)12/15/2026Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Red Zone (2m+) 1-Year History Sep 25 Dec 25 Mar 26 Jun 26 Sep 26 NMTC's financial health is in the Red zone, according to TradeSmith. NMTC has been in this zone for over 2 months. Industry, Sector and Symbol Stock ExchangeNASDAQ SectorHealthcare Industry Healthcare Equipment & Supplies Sub-IndustryHealthcare Equipment Current SymbolNASDAQ:NMTC CIK1500198 Webwww.n1mtc.com Phone(952) 426-1383FaxN/AEmployees18Year FoundedN/APrice Target and Rating Average Price Target for NeuroOne Medical Technologies$7.33 High Price Target$9.00 Low Price Target$5.00 Potential Upside/Downside+451.4%Consensus RatingHold Rating Score (0-4)2.40 Research Coverage5 Analysts Profitability EPS (Trailing Twelve Months)($0.95) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$3.61 million Net Margins-71.50% Pretax Margin-74.46% Return on Equity-128.12% Return on Assets-86.34% Debt Debt-to-Equity RatioN/A Current Ratio2.84 Quick Ratio1.71 Sales & Book Value Annual Sales$12.10 million Price / Sales1.00 Cash FlowN/A Price / Cash FlowN/A Book Value$0.85 per share Price / Book1.56Miscellaneous Outstanding Shares9,110,000Free Float8,031,000Market Cap$12.12 million OptionableOptionable Beta0.65 7 Energy Stocks to Buy and Hold ForeverWith the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.Get This Free Report This page (NASDAQ:NMTC) was last updated on 9/27/2026 by MarketBeat.com Staff. From Our PartnersSmall Colorado Company (Backed by Sam Altman) Could Save U.S. Power GridA small Colorado company has secured rights to technology that could prevent the U.S. public power grid from c...Altimetry | SponsoredReady to give options a try? Your first trade (Ticker included) -INSIDETired of trying tactic after tactic when it comes to options trades... only to be met with market noise and st...Base Camp Trading | SponsoredLouis Navellier: My #1 AI stock for 2026 (name & ticker inside)Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...InvestorPlace | SponsoredHere’s the stock symbol I’ve promisedWhitney Tilson of Stansberry Research has long recommended Berkshire Hathaway as a core retirement holding - b...Stansberry Research | SponsoredHere’s Why Trump Won’t End The Iran WarTrump has called an Iran deal close 38 times since the war began, yet the fighting keeps flaring back up. O...Banyan Hill Publishing | SponsoredBank of America: 'Digital Dollar Inevitable'Bank of America just revealed your expiration date. In their Bloomberg interview, they didn't just predict the...Decentralized Masters | SponsoredThese gold assets are priced for $1,800 gold [it's over $4,000]Gold's major miners are generating record free cash flow, with margins as high as 75 percent even after gold's...Golden Portfolio | Sponsored100% overnight gains?Rumors are circulating that Elon Musk is preparing to acquire three publicly traded companies. Dr. Mark Sko...The Oxford Club | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding NeuroOne Medical Technologies Corporation Please log in to your account or sign up in order to add this asset to your watchlist. Share NeuroOne Medical Technologies With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free NMTC Stock Alerts